Friday, September 25, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryigf-1hi-tech pharmaceuticalssupplements

Hi-Tech Pharmaceuticals launches IGF-1 dietary supplement in US

The supplement brand is marketing an IGF-1 peptide ingredient through the dietary supplement channel rather than a prescription route.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 21 11:47 ETSource: nutritioninsight.com

The wire

  1. 01Hi-Tech Pharmaceuticals has launched a dietary supplement in the United States built around IGF-1, according to a report in nutritioninsight.com.
  2. 02Peptide hormones sold as supplements sit in contested regulatory territory, and clinicians and pharmacists may field patient questions about over-the-counter IGF-1 products.
  3. 03Product details, dosing and any regulatory response were not described in the available report; the company's claims are unverified.

From the source

Hi-Tech Pharmaceuticals launches IGF-1 peptide dietary supplement in the US

“Maxxing” mindset: Balchem backs creatine and magnesium pairing for active nutrition

Read at nutritioninsight.com
PeptiPrescribed peptides from $99/moSee all →